Rolf M. Huseby
Keine laufenden Positionen mehr
Profil
Rolf M.
Huseby worked as a Principal at Eli Lilly & Co. and as a Vice President at Smithkline Beckman Corp and Baxter Laboratories, Inc. He also worked as a VP-Advanced Research & Product Development at ApoVax, Inc. Dr. Huseby received his undergraduate and doctorate degrees from the University of Louisville.
Ehemalige bekannte Positionen von Rolf M. Huseby
| Unternehmen | Position | Ende |
|---|---|---|
| Baxter Laboratories, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Smithkline Beckman Corp
 Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
ApoVax, Inc.
 ApoVax, Inc. Medical/Nursing ServicesHealth Services ApoVax, Inc. developed immunotherapies and therapeutic vaccines. It was a biotechnology company that developed novel immunotherapies, which are treatments based on regulating the host immune system to fight disease. The firm was a scientific foundation that built on two platform technologies that are used to modulate the immune system-ProtEx and ApoVax. The company was founded by Haval Shirwan in 2001 and was headquartered in Louisville, KY. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Rolf M. Huseby
| University of Louisville | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ApoVax, Inc.
ApoVax, Inc. Medical/Nursing ServicesHealth Services ApoVax, Inc. developed immunotherapies and therapeutic vaccines. It was a biotechnology company that developed novel immunotherapies, which are treatments based on regulating the host immune system to fight disease. The firm was a scientific foundation that built on two platform technologies that are used to modulate the immune system-ProtEx and ApoVax. The company was founded by Haval Shirwan in 2001 and was headquartered in Louisville, KY. | Health Services |
Smithkline Beckman Corp
Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Health Technology |
| Baxter Laboratories, Inc. |